MY151198A - A medicament for treating dengue - Google Patents

A medicament for treating dengue

Info

Publication number
MY151198A
MY151198A MYPI20092756A MY151198A MY 151198 A MY151198 A MY 151198A MY PI20092756 A MYPI20092756 A MY PI20092756A MY 151198 A MY151198 A MY 151198A
Authority
MY
Malaysia
Prior art keywords
medicament
extracted
boesenbergia
treating dengue
treating
Prior art date
Application number
Inventor
Rohana Prof Dr Yusof
Noorsaadah Abdul Prof Dr Rahman
Norzulaani Prof Dr Khalid
Mudiana Muhamad Mohd Saufi
Tan Siew Kiat
Original Assignee
Univ Malaya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Malaya filed Critical Univ Malaya
Priority to MYPI20092756 priority Critical patent/MY151198A/en
Publication of MY151198A publication Critical patent/MY151198A/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

THE INVENTION PROVIDES A GROUP OF MEDICAMENT FOR TREATING FLAVIVIRUS INFECTION, SUCH AS THE SEROTYPE 2 DENGUE VIRAL INFECTION IN HUMAN BODY. THE INHIBITORS CAN BE EXTRACTED AND/OR PURIFIED PLANT SPECIES SUCH AS BOESENBERGIA ROTUNDA, BOESENBERGIA PANDURATA AND THE LIKES. THESE MEDICAMENTS SHALL COMPRISE OF THERAPEUTICALLY EFFECTIVE AMOUNT OF THE BIOACTIVE COMPOUNDS EXTRACTED FROM THE PLANT.
MYPI20092756 2009-06-29 2009-06-29 A medicament for treating dengue MY151198A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20092756 MY151198A (en) 2009-06-29 2009-06-29 A medicament for treating dengue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20092756 MY151198A (en) 2009-06-29 2009-06-29 A medicament for treating dengue

Publications (1)

Publication Number Publication Date
MY151198A true MY151198A (en) 2014-04-30

Family

ID=52595622

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20092756 MY151198A (en) 2009-06-29 2009-06-29 A medicament for treating dengue

Country Status (1)

Country Link
MY (1) MY151198A (en)

Similar Documents

Publication Publication Date Title
EP2493464A4 (en) Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms
MX2013003634A (en) Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases.
MX340515B (en) Vasoprotective and cardioprotective antidiabetic therapy.
BR112013029201A2 (en) pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
BRPI1007379B8 (en) pharmaceutical compositions for the treatment or prevention of oral infections by e. coli
PH12015500724B1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
IN2012DN00971A (en)
IL206563A (en) Therapeutic composition or medicament comprising a suspension of red corpuscles encapsulating asparginase for use in the treatment of pancreatic cancer
GB201208879D0 (en) Therapeutic for treating Clostridium difficile infection
MX350746B (en) Novel cyclosporin derivatives for the treatment and prevention of a viral infection.
SG10201406288SA (en) Multimeric forms of antimicrobial peptides
MX2012000136A (en) Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections.
EP2438923A4 (en) Composition for preventing or treating obesity-related diseases mediated by the activation of ampk and including 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignans as active ingredients
MX2010009270A (en) Compounds and methods for the prevention or treatment of restenosis.
AR093182A1 (en) METHOD TO TREAT OVERWEIGHT OR OBESITY
IL202351A (en) Substituted (2-oxo-1,3-oxazolidin-5-yl)methyl-thiophene-2-carboxamides, process for preparing same and use thereof for preparing medicaments for the treatment and/or prophylaxis of diseases
MX336278B (en) Compositions and methods for prevention and treatment of wounds.
MX2015005733A (en) Tricyclic compounds for use in the treatment and/or control of obesity.
MY165964A (en) Preventive or therapeutic agent for fibrosis
MY182553A (en) Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
PH12018502568A1 (en) Composition comprising at least one enzyme and at least one microbicidal molecule for the prevention or treatment of post-implant infections
MX2015006779A (en) Protein slurp-1 for use in the treatment of ocular diseases.
MY151198A (en) A medicament for treating dengue
NZ600187A (en) Pharmaceutical composition for treating cutaneous burns
MX2014000870A (en) Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2- ylidene)-1h-benzimidazol-5-amine for treating retinal diseases.